---
document_datetime: 2023-09-21 18:43:45
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/docetaxel-kabi-epar-all-authorised-presentations_en.pdf
document_name: docetaxel-kabi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0286507
conversion_datetime: 2025-12-15 00:56:31.488183
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength     | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|--------------|---------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/12/770/001  | Docetaxel Kabi    | 80 mg/ 4 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 4 ml                      | 1 vial      |
| EU/1/12/770/002  | Docetaxel Kabi    | 120 mg/ 6 ml | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 6 ml                      | 1 vial      |
| EU/1/12/770/003  | Docetaxel Kabi    | 160 mg/ 8 ml | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 8 ml                      | 1 vial      |
| EU/1/12/770/004  | Docetaxel Kabi    | 180 mg/ 9 ml | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 9 ml                      | 1 vial      |
| EU/1/12/770/005  | Docetaxel Kabi    | 20 mg/ 1 ml  | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 1 ml                      | 1 vial      |